viernes, 30 de enero de 2026

Long-Term Data With Dawnzera for the Treatment of Hereditary Angioedema by Madaline Spencer| ++++

CLINICAL PERSPECTIVES Long-Term Data With Dawnzera for the Treatment of Hereditary Angioedema https://checkrare.com/long-term-data-with-dawnzera-for-the-treatment-of-hereditary-angioedema/ Michael Manning, MD, Allergist and Immunologist, discusses long-term data with Dawnzera (donidalorsen) for the treatment of patients with hereditary angioedema (HAE). The Development of Nipocalimab for the Treatment of Sjögren’s Disease https://checkrare.com/the-development-of-nipocalimab-for-the-treatment-of-sjogrens-disease/ Ghaith Noaiseh, MD, Associate Professor of Allergy, Clinical Immunology, and Rheumatology at The University of Kansas Medical Center, discusses the development of nipocalimab for the treatment of Sjögren’s disease (SjD). Post Hoc Analysis of Long-Term Efficacy of Migalastat in Females With Fabry Disease https://checkrare.com/post-hoc-analysis-of-long-term-efficacy-of-migalastat-in-females-with-fabry-disease/ A recent post hoc analysis of long-term efficacy of migalastat in females with Fabry disease was published in the Journal of Medical Genetics. Current Trends in the Healthcare Job Market https://checkrare.com/current-trends-in-the-healthcare-job-market/ Vicki Salemi, Career Expert, discusses current trends in the healthcare job market and expectations for 2026.

No hay comentarios:

Publicar un comentario